Mitogen activated protein kinases regulation-PTH/PTHrP
Mitogen activated protein kinases regulation-PTH/PTHrP
批准号:
7046686
负责人:
HESHAM A TAWFEEK
金额:
$13.23万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2008-03-31
关键词:
3T3 cellsapoptosiscell differentiationcell growth regulationcell proliferationcell surface receptorsenzyme induction /repressionfocal adhesion kinasegenetically modified animalshormone regulation /control mechanismimmunoprecipitationlaboratory mousemitogen activated protein kinaseosteoblastsparathyroid hormone related proteinparathyroid hormonesphosphorylationprotein tyrosine kinasereceptor bindingreceptor expressiontissue /cell culturewestern blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
The ultimate goal of this K01 proposal is to provide the applicant with additional training in basic science and molecular biology to establish himself as an independent scientist. The project elucidates the molecular mechanisms and the function of PTH/PTHrP receptor regulation of Extracellular signal regulated (ERK) mitogen-activated protein (MAP) kinases. The role of non-receptor tyrosine kinases as well as the role of receptor phosphorylation in PTH activation of ERK1/2 MAP kinases in osteoblastic cell lines will be explored. Furthermore, the role of ERK1/2 MAP kinases in osteoblastic cell proliferation, differentiation and apoptosis will be investigated. Primary osteoblastic cell culture from wild type and genetically engineered mice as well as several other biochemical and pharmacological tools will be employed to achieve the goals of the study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The efficacy of β-aminoisobutyric acid myokine to reduce bone loss after spinal cord injury
-
批准号:10257699
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:HESHAM A TAWFEEK
-
依托单位:
The efficacy of β-aminoisobutyric acid myokine to reduce bone loss after spinal cord injury
-
批准号:10400101
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:HESHAM A TAWFEEK
-
依托单位:
Mitogen activated protein kinases regulation-PTH/PTHrP
-
批准号:6921672
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2005
-
负责人:HESHAM A TAWFEEK
-
依托单位:
Mitogen activated protein kinases regulation-PTH/PTHrP
-
批准号:7211514
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2005
-
负责人:HESHAM A TAWFEEK
-
依托单位:
Mitogen activated protein kinases regulation-PTH/PTHrP
-
批准号:7541265
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2005
-
负责人:HESHAM A TAWFEEK
-
依托单位:
INTERNALIZATION OF PARATHYROID HORMONE RECEPTOR
-
批准号:6516938
-
项目类别:
-
资助金额:$5.44万
-
财政年份:2002
-
负责人:HESHAM A TAWFEEK
-
依托单位:
INTERNALIZATION OF PARATHYROID HORMONE RECEPTOR
-
批准号:6397746
-
项目类别:
-
资助金额:$4.94万
-
财政年份:2001
-
负责人:HESHAM A TAWFEEK
-
依托单位:
INTERNALIZATION OF PARATHYROID HORMONE RECEPTOR
-
批准号:6140446
-
项目类别:
-
资助金额:$4.63万
-
财政年份:2000
-
负责人:HESHAM A TAWFEEK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: